CHRU De Nancy — Clinical Trial Site

511 Registered trials

261 Currently recruiting

Organisation

CHRU De Nancy

Location

Vandoeuvre Les Nancy, France

Identifier

ORG-100009792

Address

Vandoeuvre-Les-Nancy Cedex, 11 Rue Du Morvan, Bp 80001, 54511, France

Departments

#1000: Nuclear Medicine
#1001: Medecine Nucléaire
#2022: Department of Hematology
#2153: Nuclear Medicine
#3352: Médecine interne
#4005: Neurologie
#5005: Service Hématologie et Médecine Interne
10021: Service d'Hépato- Gastroentérologie
1007: Medecine Interne et Immunologie Clinique
1200 Nuclear Medicine
1205: Medecine Nucleaire
1704: Pediatric Oncology/Hematology
2048: Service de Néphrologie
2048:Service de Néphrologie
2159: Médecine Nucléaire
2305: Service Hématologie et Médecine Interne
2400: Hématologie
2402: Hématologie
2421: Endocrinology, diabetology and Nutrition
3014:Pediatric - Allergology
33002:Service d’Oncohématologie Pédiatrique
4005: Neurologie
406: Médecine Nuclaire
54
54035
54500
54511
7013:Neurology
Allergologie Pédiatrique
Anesthésie - Réanimations
Anesthésie réanimation
Anesthésie- Réanimation
Anesthésie-réanimation
cardiologie
Cardiologie - Unité de soins intensifs de cardiologie
Cardiology
Cardiology/EP
Centre de Référence des Maladies Neuromusculaires
Centre de référence SLA
Centre Investigation Clinique Plurithématique
chirugie Digestive et oncologique
Chirurgie
Chirurgie cancérologique digestive, hépato-bilio-pancréatique et colorectale
Chirurgie cancérologique digestive, hepato bilio pancréatique et colorectale
Chirurgie cardiaque
Chirurgie Digestive hépatobiliaire, endocrinienne et cancérologique
Chirurgie viscérale et digestive
Chirurgie Viscérale Infantile
CHRU de Nancy
CHRU Nancy - site Brabois - Endocrinologie - Diabétologie - Nutrition
CHU Brabois - Service d'hématologie clinique
CIC plurithématique
Clinic Investigation Unit
Clinical Haematology
Clinical Investigation Unit
Département d'hématologie
Département d’Anesthésie-Réanimation et Médecine Périopératoire
Département d’Endocrinologie
Departement de Cardiologie
Département de pneumologie
Département Gériatrie Aigue
Départment Gériatrie Aigue
Department of Hepato-Gastro-Enterology
Department of Neurology
Dermatology
Dermatology department
Diagnostic and therapeuthic Neuroradiology
Digestive surgery
Dpt d'Hémato-Onco-Pédiatrie & Transplantation Médullaire
Emergency
endocrinologie
Endocrinologie diabetologie
Endocrinologie, Diabétologie et de Nutrition
Endocrinologie, Diabetologie, Nutrition
endocrinology
Endocrinology Diabetology and Nutrition
Endocrinology, Diabetology and Nutrition
FR10004: Service d'Hépato-Gastroentérologie
FR10010: Service d'Hépato- Gastroentérologie
FR10014: Service d'Hépato-Gastroentérologie
Gastro-Entérologie
GASTRO-ENTEROLOGIE ET HEPATOLOGIE
Gastro-entérologie et hépatologique
GASTROENTEROLOGIE
Gastroentérologie et hépatologie
Gastroenterology
Gastroenterology - clinical Investgation Unit
Gastroenterology - Clinical investigation unit
Gastroenterology and Hepatology
Gastroenterology- Clinical investigation unit
Génétique Clinique
Geriatry
GI
Gynaecology-Obstetrics
Gynécologie
Gynécologie Obstétrique
Gynécologie-Obstétrique
Gynecology
Gynecology-obstetric
haemato-oncology paediatric
Haematology
Haematology and Internal Medicine
Hématologie
Hématologie - Medecine interne
Hématologie adulte
HEMATOLOGIE ADULTE - 7eme ETAGE
Hématologie Biologique
hématologie clinique
Hématologie et oncologie pédiatrique
Hématologie Médecine Interne
Hématologie Oncologie
Hématologie, CHRU NANCY - HOPITAUX DE BRABOIS
Hematology
Hematology and Intern Medicine
Hematology Department
Hematology-oncology department
Hepato Gastroenterology Department
Hépato-Gastro-Entérologie
Hepato-gastro-enterology
Hepato-Gastro-Enterology Department
Hépato-Gastroentérologie
Hepato-gastroenterology
Hepatogastro-enterology
hepatogastroenterologie
Hepatogastroenterology
Hepatogastroenterology department
Hôpital Brabois - Service d'hématologie clinique
Hôpital centre Neurologie
Hôpitaux de Brabois
Hôpitaux de Brabois Service Hématologie
Hôpitaux de Brabois, Endocrinology, Diabetology and Nutrition department
Hôpitaux de Brabois, Gastroenterology
Hôpitaux de Brabois, Hepato-gastroenterology
ICU
INFECTIOLOGIE
Infectious diseas
Infectious Diseases
Infectious diseases department
Inflammatory Bowel Disease (IBD) Unit
Intensive care
Intensive Care Unit
Internal Medecine
Internal medicine
Internal medicine and clinical immunology
Internal Medicine and Clinical Immunology Department
Interventional Neuroradiolology department
Maladies Infectieuses
Maternité du CHRU de Nancy - Gynécologie Obstétrique
Médecine Infantile
Médecine Infantile 2
médecine intensive - réanimation
médecine intensive et réanimation
medecine intensive réanimation
Médecine interne
Médecine Interne et Immunologie
Médecine Interne et Immunologie Clinique
Médecine Interne Immunologie Clinique
medecine néonatale
Médecine Nucléaire
medecine nuclear department
Médecine Vasculaire
Medical ICU
Medical oncology
Meurthe-et-Moselle
N/A
NA
Neonatology
Néphrologie
Néphrologie Pédiatrique
Néphrologie-Transplantation Rénale et Hémodialyse
Nephrology
Nephrology and Dialysis
Neuro-oncologie
Neuro-oncology
Neurologie
Neurology
Neurology department
Neuroradiologie Diagnostique et Thérapeutique
Neuroradiologie interventionnelle
Neurosurgery for pediatrics
NRI
Nuclear Medicine
nuclear medicine unit
Obstetric gynecology
Obstetric-gynécolgy
Onco hématologie pédiatrique
Onco-hématologie pédiatrique
Onco-pediatry
Oncologie
Oncology
oncology department
Oncology for adults
Oncology for pediatrics
Onologie-hématologie Pédiatrique
Ophtalmology
Paediatric haematology oncology
Paediatric onco-haematology unit
Ped Oncology
Pediatric Allergology
Pediatric hemato-oncology
Pediatric Hematology
pediatric intensive care unit
pediatric oncology
Pediatrics
Pédiatrie
Pneumologie
Pneumology
Pneumology (study is conducted at Rue de Morvan)
Pneumology Department
Pneumonology
Reproductive medicine
Rheumatology
Rhumatologie
Samu - Smur - Service des Urgences
SAMU 54
Service d’Hematologie Clinique
Service Cardiologie
Service d Hematologie
Service d' Hémato-Oncologie Pédiatrique
Service d'Endocrinologie, Diabéte et Nutrition
Service d'hématologie
Service d'hématologie clinique
Service d'hématologie et Médecine interne
Service d'Hépato-Gastro-Entérologie
Service d'Hépato-gastroentérologie
Service d'HGE, CHRU de Nancy-Hôpitaux de Brabois, 5 rue du Morvan, 54500 Vandoeuvre-lès-Nancy
Service d'oncologie pédiatrique
Service d’hémato-oncologie pédiatrique
Service d’Hématologie
Service d’Hématologie-médecine interne
Service d’hépato-gastroentérologie
SERVICE D’HEPATOGASTROENTEROLOGIE
Service d’Hépatologie et de gastroentérologie
Service d’obstétrique et médecine foetale
Service d’onco-hématologie pédiatrique
Service d’Onco-hématologie pédiatrique, Hôpital d’enfants, CHU de Nancy
Service de cardiologie
Service de Dermatologie
SERVICE DE GASTROENTEROLOGIE
Service de Gynécologie obstétrique
Service de Médecine Infantile
Service de Médecine Intensive Réanimation
Service de Médecine Interne
Service de médecine nucléaire
Service de Néphrologie
Service de neurologie
Service de Neurologie, Unité Neurovasculaire
Service de Pneumologie
Service Endocrinologie Diabetologie & Nutrition
Service Hématologie
Service hématologie adulte
Service Hematologie et Medecine Interne
Service Hépato Gastro Entérologie
Service Hépato-Gastro-Entérologie
Service Hépato-gastroentérologie
Service néphrologie
Service neurologie
Service Onco-Hematologie pédiatrique
Service Oncologie Pediatrique
Site 001 - Service d'Hepato-Gastroenterologie
Unité d'investigation clinique - Gastroentérologie
Unité de Soins Intensifs de Cardiologie
Unité Neurovasculaire
Unité Neurovasculaire - Bâtiment Neurologie
Urologie
Vascular
vascular medicine

Clinical trials at this site (511)

Search interface

Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Crohn's Disease Ended

2023-504741-32-00 Moderately to Severely Active Crohn's Disease 4 2022-11-30
Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Moderately to Severely Active Ulcerative Colit… Ended

2023-504743-13-00 Moderately to Severely Active Ulcerative Colitis 4 2022-11-30
Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn's Disease Ended

2023-504740-33-00 Fistulizing perianal Crohn's Disease 5 2022-11-22
Impact of a treatment with angiotensin receptor blocker on outcome after acute kidney injury in patients discharged from the ICU “START-or-N… Ended

2024-515845-40-00 Acute kidney injury 5 2022-11-22
A global study to evaluate transarterial chemoembolization(TACE) in combination with durvalumab, tremelimumab +/-lenvatinib therapy compared… Ended

2023-508701-24-00 Locoregional Hepatocellular Carcinoma (HCC) 5 2022-11-21
A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With N… Ended

2024-510947-71-00 Chronic Myeloid Leukemia 5 2022-11-21
RITUX-PLUS 2 : A phase 3 randomized and double-blind controlled trial comparing the efficacy and safety of rituximab combined with subcutane… Ended

2024-516168-27-00 Adult patients with persistent or chronic immune thromb 5 2022-11-10
This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in… Ended

2023-505628-67-00 Relapsed and Refractory Follicular Lymphoma 5 2022-10-28
Study of efficacy, safety and tolerability of ianalumab versus placebo, in combination with SoC therapy, in participants with active lupus n… Ended

2023-508559-37-00 Lupus nephritis 5 2022-07-14
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients with Multiple Sclerosis Ended

2023-505974-14-00 Multiple Sclerosis (MS) 5 2022-06-23
A clinical study that compares a treatment with Iberdomide, Daratumumab and Dexamethasone against a treatment with Daratumumab, Bortezomib, … Ended

2024-510800-35-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2022-06-17
Intravenous Immunoglobulin plus oral prednisone or high-dose dexamethasone, for adults with immune thrombocytopenia (ITP) with moderate and … Ended

2024-516403-16-00 Adult patients with immune thrombocytopenia (ITP) with 5 2022-04-07
PCL-2 - PRIMARY PLASMA CELL LEUKEMIA: A PROSPECTIVE PHASE II STUDY INCORPORATING DARATUMUMAB TO CHEMOTHERAPY AND STEM CELL TRANSPLANTATION (… Ended

2024-515037-15-00 PRIMARY PLASMA CELL LEUKEMIA: A PROSPECTIVE PHASE II ST 4 2022-03-02
A Randomized Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults … Ended

2023-503640-14-00 Newly diagnosed Philadelphia-negative B-cell precursor 5 2022-02-17
OASIS II - A randomized phase II trial evaluating Ibrutinib plus CD20 Ab and Ibrutinib-Venetoclax plus CD20 Ab in patients with untreated ma… Ended

2024-512634-15-00 Patients with untreated mantle cell lymphoma 9 2022-01-05
VERLEN - Phase II, Open-Label Study evaluating efficacy of Lenalidomide and Tafasitamab combination associated to Rituximab in frontline Dif… Ended

2023-507286-25-00 Diffuse Large B-Cell Lymphoma 4 2021-12-23
A clinical study to assess the efficacy and safety of lanifibranor followed by an active treatment extension in adult patients with non-cirr… Ended

2023-508248-23-00 Non-alcoholic steatohepatitis (NASH) 5 2021-11-26
FILOCLL14 - STAIR : "Open-label, phase 2 study investigating the STop and restart Acalabrutinib In fRrail patients with previously untreated… Ended

2024-513936-80-00 elderly patients (> 70 years) with CLL or SLL 4 2021-11-12
A Phase 3 Trial of Fixed Duration Pirtobrutinib (LOXO-305) plus Venetoclax and Rituximab versus Venetoclax and Rituximab in Previously Treat… Ended

2023-507698-16-00 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 5 2021-10-14
DALY 2-EU Ended

2023-506270-13-00 Relapsed/refractory diffuse large B cell lymphoma (R-R 4 2021-07-27
Hydrocorticose and vasopressin in post-resuscitation syndrome Ended

2024-516373-77-00 Adult cardiac arrest patients with sustained ROSC and h 5 2021-07-18
Long-term safety of apraglutide in short bowel syndrome Ended

2023-510389-28-00 short bowel syndrome 5 2021-06-14
Trial comparing the efficacy and safety of tafasitamab plus lenalidomide in addition to standard therapy versus standard therapy in patients… Ended

2022-500237-92-00 Newly-diagnosed high-intermediate and high-risk diffuse 5 2021-04-23
Double blind, multicentric, randomized, placebo-controlled trial, evaluating the efficacy of 24-month of bezafibrate in primary sclerosing c… Ended

2024-511658-28-01 primary sclerosing cholangitis 5 2021-04-06